Marshall & Sterling Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.2K Buy
279
+1
+0.4% +$263 0.05% 131
2026
Q1
$74.3K Hold
278
0.05% 126
2025
Q4
$69.7K Buy
278
+1
+0.4% +$266 0.05% 122
2025
Q3
$79.5K Hold
277
0.05% 131
2025
Q2
$72.5K Buy
277
+2
+0.7% +$487 0.05% 126
2025
Q1
$64.1K Hold
275
0.04% 129
2024
Q4
$63K Buy
+275
New +$63.1K 0.04% 113

Other funds holding LH

Marshall & Sterling Wealth Advisors's LH Position: Q2 2026 in Review

Marshall & Sterling Wealth Advisors increased its Labcorp (LH) stake by 0.36% in Q2 2026, buying an estimated $263 and bringing the position to 279 shares worth $78.2K. The position accounts for 0.05% of the portfolio, ranked #131.

Marshall & Sterling Wealth Advisors first reported a position in LH in Q4 2024 and has held it in 7 quarters since. The position peaked at $79.5K in Q3 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Marshall & Sterling Wealth Advisors held 279 shares of Labcorp worth $78.2K as of Q2 2026.
  • Marshall & Sterling Wealth Advisors bought 1 Labcorp share in Q2 2026, an estimated $263.
  • Labcorp made up 0.05% of Marshall & Sterling Wealth Advisors's portfolio in Q2 2026, its #131 holding.
  • Marshall & Sterling Wealth Advisors first reported a position in Labcorp in Q4 2024 and has held it in 7 quarters since.
  • Marshall & Sterling Wealth Advisors's Labcorp position peaked at $79.5K in Q3 2025.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.